Inspiration Healthcare Group plc announced the appointment of Alan Olby ACA as Director of the Company, effective June 12, 2023. Alan is an experienced and commercially focused healthcare CFO, with extensive international and operational experience within fast-growing listed and private healthcare companies. He spent 16 years at Sinclair Pharma, of which 12 years were as CFO and a member of the executive leadership team and he was instrumental in transforming the company into a fast growth global aesthetics business, which was sold to Huadong Medicine Co Ltd. for £165 million in 2018.

During his tenure he oversaw several successful capital raises, and a number of strategic M&A transactions, including the disposal of the non-core business to Alliance Pharma for £132 million in 2015. Prior to Sinclair Pharma, Alan was Group Financial Controller of Xenova Group plc and KS Biomedix plc. Alan Olby resigned as a director of Speciality European Pharma International AG in the 12 months prior to the company going into liquidation on 29 November 2018.

Other than the award of share options, as noted below, Alan Olby has no existing interest in the ordinary shares of the Company.